We aim to produce a new generation compound encapsulating a Non-opioid analgesic to treat mild-to-moderate pain in a variety of medical conditions. Clinova is currently completing phase 3 studies of Clin3004 and we expect the candidate to progress to launch in 2013.
The following tables shows our clinical-stage compounds that we are developing internally or are co-developing with a partner. Please click the relevant codename for more information:
| Code Name | Brand Name | Indication | Pre Clinical | Pre Marketing (Early) | Pre Marketing (Middle) | Pre Marketing (Late) | Market Preparation / Launch |
|---|---|---|---|---|---|---|---|
| CLIN 3001 | Covaflu mask FFP2 | Pandemic Respirator | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3002 | Covaflu mask FFP3 | Pandemic respirator | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3003 | Quash | Hand Sanitizer | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3004 | TBC | Painkiller | Complete |
Complete |
Complete |
Current |
Not reached |
| CLIN 3005 | Stemaderm™ Cream | Topical skincare cream | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3011 | TBC | Indigestion remedy | Complete |
Complete |
Complete |
Current |
Not reached |
| CLIN 3012 | Repelsect ™ | Insect patch repellent | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3018 | ORS | Effervescent Tablets | Complete |
Complete |
Complete |
Complete |
Current |